Key result
Review outlines considerations for DOAC use in renal support therapy amid scarce clinical data.
This review highlights the scarcity of clinical trial data and outlines key considerations for prescribing DOACs in patients undergoing renal support therapy.
No takes yet. Share an insight, caveat, or question.
Scarcity of data warrants caution with DOACs in renal support therapy; leaves open need for dedicated trials.
Dager et al. (2017) conducted a review in Renal support therapy requiring anticoagulation. Direct acting oral anticoagulants (DOACs) was evaluated. A review of available literature highlights the scarcity of data and outlines considerations for using direct acting oral anticoagulants in patients undergoing renal support therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: